Tocilizumab lowers risk of death for critical COVID-19 patients on ventilators, finds study
Patients who received tocilizumab in the retrospective, single-centre study were…
Patients who received tocilizumab in the retrospective, single-centre study were 45 percent less like to die and more likely to come off ventilation within 28 days.